False Suffocation Alarms, Spontaneous Panics, and Related Conditions: An Integrative Hypothesis

Archives of General Psychiatry

Volumn 50, Issue 4, 1993, Pages 306-317

  Klein, Donald F ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CARBON DIOXIDE; LACTIC ACID; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ASPHYXIA; FEAR; HUMAN; HYPERVENTILATION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYSTERIA; LACTATION; MENSTRUAL CYCLE; PANIC; PHOBIA; PREGNANCY; PRIORITY JOURNAL; SEPARATION ANXIETY; SLEEP;

ASPHYXIA; CARBON DIOXIDE; DIAGNOSIS, DIFFERENTIAL; FEAR; HUMAN; HYPERVENTILATION; LACTATES; MODELS, BIOLOGICAL; PANIC DISORDER; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027528446     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1993.01820160076009     Document Type: Article

References (188)

1. Mayr E. Toward a New Philosophy of Biology. Cambridge, Mass: Harvard University Press; 1988: 2–3.
2. Kety SS, Schmidt CF. The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption on normal young men. J Clin Invest. 1948;27: 484–492.
3. Williams HI. Carbon dioxide poisoning: report of eight cases, with two deaths. BMJ. 1958;4: 1012–1014.
4. McNally WD. Toxicology. Chicago, III: Industrial Medicine Publishing Co; 1937.
5. Liebowitz MR, Gorman JM, Fyer AJ, Levitt M, Dillon D, Levy G, Appleby IL, Anderson S, Palij M, Davies SO, Klein DF. Lactate provocation of panic attacks, II: biochemical and physiological findings. Arch Gen Psychiatry. 1985;42: 709–719.
6. Rachman SJ. Fear and Courage. 2nd ed. New York, NY: WH Freeman & Co; 1990: 87–102.
7. Brooks FR, Ebner DG. Psychological reactions during chemical warfare training. Mil Med. 1983;148: 232–235.
8. Barlow DH. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. New York, NY: Guilford Press; 1988.
9. McMillan TM, Rachman SJ. Fearlessness and courage in paratroopers undergoing training. Person Indiv Diff. 1988;9: 373–378.
10. Cohen ME, White PD. Life situations, emotions and neurocirculatory asthenia (anxiety neurosis, neurasthenia, effort syndrome). Proceedings of the Association of Research in Nervous and Mental Disease. 1951;13: 335–357.
11. Cowley DS, Roy-Byrne PP. Hyperventilation and panic disorder. Am J Med. 1987;83: 929–936.
12. Nutt DJ. The pharmacology of human anxiety. Pharmacol Ther. 1990;47: 233–266.
13. Uhde TW, Siever LJ. Relationship of plasma free MHPG to anxiety and psychophysical pain in normal volunteers. Psychopharmacol Bull. 1982;18: 129–132.
14. Ward MM, Mefford IN, Parker SD, Chesney MA, Barr Taylor C, Keegan DL, Barchas JD. Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors. Psychosom Med. 1983;45: 471–486.
15. Anderson DJ, Noyes R, Crowe RR. A comparison of panic disorder and generalized anxiety disorder. Am J Psychiatry. 1984;141: 572–575.
16. Van den Hout M, de Jong P, Zandbergen J, Merckelbach H. Waning of panic sensations during prolonged hyperventilation. Behav Res Ther. 1990;28: 445–448.
17. Dejours P. Chemoreflexes in breathing. Psychol Rev. 1962;42: 335–358.
18. Gorman JM, Goetz RR, Dillon D, Liebowitz MR, Fyer AJ, Davies S, Klein DF. Sodium D-lactate infusion of panic disorder patients. Neuropsychopharmacology. 1990;3: 181–189.
19. Dager SR, Reiney JM, Kenny MA, Bowden DM. D-,L-lactate infusion in non-human primates: central and peripheral effects. Biol Psychiatry. 1989;25:152A.
20. Dager SR, Reiney JM, Kenny MA, Artru AA, Metzger GD, Bowden DM. Central nervous system effects of lactate infusion primates. Biol Psychiatry. 1990;27: 193–204.
21. Dager SR, Marro KI, Richards TL, Metzger G D. MRS detection of whole brain lactate rise during on M sodium lactate infusion in rats. Biol Psychiatry. In press.
22. Siesjo BK, Johannsson H, Ljunggren B, Norberg K. Brain dysfunction in cerebral hypoxia and ischemia. In: Plum F, ed. Brain Dysfunction in Metabolic Disorders. New York, NY: Raven Press; 1974: 75–112.
23. Krendel DA, Pilch JF, Stahl RL. Central hyperventilation in primary CNS lymphoma: evidence implicating CSF lactic acid. Neurology. 1991;41: 1156–1157.
24. Pauzner R, Mouallem M, Sadeh M, Tadmor R, Farfel Z. High incidence of primary cerebral lymphoma in tumor-induced central neurogenic hyperventilation. Arch Neurol. 1989;46: 510–512.
25. Hensen EL, Kristensen HS, Broderson P, Paulson OB, Mullertz S, Jessen O. Acid-base pattern of cerebrospinal fluid and arterial blood in bacterial meningitis and in encephalitis. Acta Med Scand. 1974;196: 431–437.
26. Rodriguez M, Baele PL, Marsh HM, Okazaki H. Central neurogenic hyperventilation in an awake patient with brainstem astrocytoma. Ann Neurol. 1982;11: 625–628.
27. Stein JM, Papp LA, Klein DF, Cohen S, Simon J, Ross D, Martinez J, Gorman JM. Exercise tolerance in panic disorder patients. Biol Psychiatry. In press.
28. Jones NL, Robertson DG, Kane JW, Hart RA. Effect of hypoxia on free fatty acid metabolism during exercise. J Appl Physiol. 1972;33: 733–738.
29. Sutton JR. The effect of acute hypoxia on the hormonal response to exercise. J Appl Physiol. 1977;42: 587–592.
30. Orwin A. The running treatment: a preliminary communication on a new use for an old therapy (physical activity) in the agoraphobic syndrome. Br J Psychiatry. 1973;122: 175–179.
31. Cannon WB. Bodily Changes in Pain, Fear, Hunger and Rage. New York, NY: Appleton & Co; 1920.
32. Selye H. The Stress of Life. New York, NY: McGraw-Hill International Book Co; 1956.
33. Levi L. Emotions, Their Parameters and Measurement. New York, NY: Raven Press; 1975.
34. Kathol RG, Noyes RJr, Lopez AL, Reich JH. Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Psychiatry Res. 1988;24: 211–221.
35. Uhde TW, Joffe RT, Jimerson DC, Post RM. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biol Psychiatry. 1988;23: 575–585.
36. Kathol RG, Anton R, Noyes R, Gehris T. Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder. Biol Psychiatry. 1989;25: 873–878.
37. Kathol RG, Noyes R, Lopez A. Similarities in hypothalamic-pituitaryadrenal axis activity between patients with panic disorder and those experiencing external stress. Psychiatr Clin North Am. 1988;11: 335–348.
38. Axelrod J, Reisine TD. Stress hormones: their interaction and regulation. Science. 1984;224: 452–459.
39. Nesse RM, Curtis GC, Thyer BA, McCann DS, Huber-Smith MJ, Knofp RF. Endocrine and cardiovascular responses during phobic anxiety. Psychosom Med. 1985;47: 320–332.
40. Coryell W, Noyes R. HPA axis disturbance and treatment outcome in panic disorder. Biol Psychiatry. 1988;24: 762–766.
41. Lopez AG, Kathol RG, Noyes R. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinology. 1990;15: 23–28.
42. Coryell W, Noyes R, Schlechte J. The significance of HPA axis disturbance in panic disorder. Biol Psychiatry. 1989;25: 989–1002.
43. Westberg P, Modigh K, Lisjo P, Eriksson E. Higher post-dexamethasone serum cortisol levels in agoraphobic than in non-agoraphobic panic disorder patients. Biol Psychiatry. 1991:30: 247–256.
44. Coryell W, Noyes R, Clancey J, Crowe R, Chaudhry D. Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks. Psychiatry Res. 1985;15: 301–311.
45. Garvey M, Noyes R, Cook B. Comparison of panic disordered patients with high versus low MHPG. J Affect Disord. 1990;20: 7–12.
46. Liebowitz MR. Antidepressants in panic disorder. Br J Psychiatry. 1989;155(suppl 6): 46–52.
47. Nesse RM, Cameron OG, Curtis GC, Lee M. How antipanic drugs might work. Am J Psychiatry. 1986;143:945.
48. Klein DF, Klein HM. The definition and psychopharmacology of spontaneous panic and phobia: a critical review I. In: Tyrer PJ, ed. Psychopharmacology of Anxiety. New York, NY: Oxford University Press; 1989: 135–162.
49. Klein DF, Klein HM. The nosology, genetics and theory of spontaneous panic and phobia: a critical review II. In Tyrer PJ, ed. Psychopharmacology of Anxiety. New York, NY: Oxford University Press; 1989: 163–195.
50. Klein DF. The pharmacological validation of psychiatric diagnosis. In: Robbins LN, Barrett J, eds. Validity of Psychiatric Diagnosis. New York, NY: Raven Press; 1989: 203–216.
51. Klein DF. Anxiety reconceptualized. In: Klein DF, Rabkin JG, eds. Anxiety: New Research and Changing Concepts. New York, NY:Raven Press; 1981: 235–262.
52. Mellins RB, Balfour HH, Turino GM, Winters RW. Failure of automatic control of ventilation (Ondine's curse). Medicine. 1970;49: 487–504.
53. Haddad GG, Mazza NM, Defendini R, Blanc WA, Driscoll JM, Epstein MAF, Epstein RA, Mellins RB. Congenital failure of automatic control of ventilation, gastrointestinal motility and heart rate. Medicine. 1978;57: 517–526.
54. Lee YJ, Curtis GC, Weg JG, Abelson JL, Modell JG. Doxapram: a novel panicogenic probe. Presented at the 144th Annual Meeting of the American Psychiatric Association; May 4, 1991; New Orleans, La.
55. Pohl R, Yeragani VK, Balon R. The effect of isoproterenol on panic disorder patients after antidepressant treatment. Biol Psychiatry. 1990;28: 203–214.
56. Woods SW, Charney DS, Delgado PL, Heninger GR. The effect of long-term imipramine treatment on carbon dioxide-induced anxiety in panic disorder patients. J Clin Psychiatry. 1990;51: 505–507.
57. Charney DS, Woods SW, Price LH, Goodman WK, Glazer WH, Heninger GR. Noradrenergic dysregulation in panic disorder. In: Ballenger JC, ed. Neurobiology of Panic Disorder. New York, NY: Alan R Liss Inc; 1990: 91–106.
58. Dorow R, Horowski R, Paschelke G, Amin M, Braestrup C. Severe anxiety induced by FG 7142, 2a B-carboline ligand for benzodiazepine receptors. Lancet. 1983;2: 98–99.
59. Roache JD, Griffiths RR. Interactions of diazepam and caffeine: behavioral and subjective dose effects in humans. Pharmacol Biochem Behav. 1987;26: 801–812.
60. Matilla M, Sepalla T, Matilla J. Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam. Int Clin Psychopharmacol. 1988;3: 215–229.
61. Klein DF, Klein HM. The substantive effect of variations in panic measurement and agoraphobia definition. J Anxiety Disord. 1989;3: 45–56.
62. Breier A, Albus M, Pickar D, Zahn TP, Wolkowitz OM, Paul SM. Controllable and uncontrollable stress in humans: alterations in mood and neuroendocrine and psychophysiological function. Am J Psychiatry. 1987;144: 1419–1425.
63. Charney D, Heninger G, Jatlow P. Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry. 1985;42: 223–243.
64. Uhde TW, Boulenger JP, Jimerson DC, Post RM. Caffeine: relationship to human anxiety, plasma MHPG, and cortisol. Psychopharmacol Bull. 1984;20: 426–430.
65. Kahn RS, Asnis GM, Wetzler S, van Praag HM. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology. 1988;96: 360–364.
66. Charney DS, Woods SW, Goodman WK, Heninger GR. Serotonin function in anxiety, II: effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology. 1987;92: 14–24.
67. Woods SW, Charney DS. Biologic responses to panic anxiety elicited by nonpharmacologic means. In: Ballenger JC, ed. Neurobiology of Panic Disorder. New York, NY: Alan R Liss Inc; 1990: 205–217.
68. Hollander E, Liebowitz MR, Gorman JM, Cohen B, Fyer A, Klein DF. Cortisol and sodium lactate-induced panic. Arch Gen Psychiatry. 1989;46: 135–140.
69. Levin AP, Doran AR, Liebowitz MR, Fyer AJ, Gorman JM, Klein DF, Paul SM. Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Res. 1987;21: 23–32.
70. Woods SW, Charney DS, Goodman WK, Heninger GR. Carbon dioxide-induced anxiety: behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. Arch Gen Psychiatry. 1988;45: 43–52.
71. Gorman JM, Battista D, Goetz RR, Dillon DJ, Liebowitz MR, Fyer AJ, Kahn JP, Sandberg D, Klein DF. A comparison of sodium bicarbonate and sodium lactate infusion in the induction of panic attacks. Arch Gen Psychiatry. 1989;46: 145–150.
72. Woods SW, Charney DS, Goodman WK, Heninger GR. Carbon dioxide-induced anxiety; behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. Arch Gen Psychiatry. 1988;45: 43–52.
73. Rainey J, Pohl R, Williams M, Knitter E, Freedman R, Ettedgui E. A comparison of lactate and isoproterenol anxiety states. Psychopathology. 1984;17(suppl 1): 66–73.
74. Uhde TW. Caffeine provocation of panic: a focus on biological mechanisms. In: Ballenger JC, ed. Neurobiology of Panic Disorder. New York, NY: Alan R Liss Inc; 1990: 219–244.
75. Nutt DJ, Glue P, Lawson C, Wilson S. Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry. 1990;47: 917–925.
76. Gorman JM, Papp LA. Respiratory physiology of panic. In: Ballenger JC, ed. Neurobiology of Panic Disorder. New York, NY: Alan R Liss Inc; 1990: 187–203.
77. Papp LA, Martinez JM, Klein DF, Ross D, Liebowitz MR, Fyer AJ, Hollander E, Gorman JM. Arterial blood gas changes in panic disorder and lactate-induced panic. Psychiatry Res. 1989;28: 171–180.
78. Den Boer JA, Westenberg GM, Klompmakers AA, van Lint LEM. Behavioral, biochemical and neuroendocrine concomiants of lactate-induced panic anxiety. Biol Psychiatry. 1989;26: 612–622.
79. Erbland ML, Ebert RV, Snow SL. Interaction of hypoxia and hypercapnia on respiratory drive in patients with COPD. Chest. 1990;97: 1289–1294.
80. Rebuck AS, Kangalee M, Pengelly LD, Campbell EJM. Correlation of ventilatory responses to hypoxia and hypercapnia. J Appl Physiol. 1973;35: 173–177.
81. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol. 1989;67: 2101–2106.
82. Bradley TD, Mateika J, Li D, Avendano M, Goldstein RS. Daytime hypercapnia in the development of nocturnal hypoxemia in COPD. Chest. 1990;97: 308–312.
83. Saltzman HA, Heyman A, Sieker HO. Correlation of clinical and physiologic manifestations of sustained hyperventilation. N Engl J Med. 1963;268: 1431–1436.
84. Baker DM. Sighing respiration as a symptom. Lancet. 1934;1: 174–177.
85. Christie RV. Some types of respiration in the neuroses. QJ Med. 1935;4: 427–432.
86. Finesinger JE. The spirogram in certain psychiatric disorders. Am J Psychiatry. 1943;100: 159–169.
87. Christophers B. The hyperventilation syndrome. Med J Aust. 1961;48: 81–86.
88. Sanderson RE, Campbell D, Laverty SG. Traumatically conditioned responses acquired during respiratory paralysis. Nature. 1962;196: 1235–1236.
89. Campbell D, Sanderson RE, Laverty SG. Characteristics of a conditioned response in human subjects during extinction trials following a single traumatic conditioning trial. J Abnorm Soc Psychol. 1964;68: 627–639.
90. Mellman TA, Uhde TW. Sleep in panic and generalized anxiety disorders. In: Ballenger JC, ed. Neurobiology of Panic Disorders. New York, NY: Alan R Liss Inc; 1990;365–376.
91. Mellman TA, Uhde TW. Electroencephalographic sleep in panic disorder: a focus on sleep related panic attacks. Arch Gen Psychiatry. 1989;46: 178–184.
92. Hauri PJ, Friedman M, Ravaris CL. Sleep in patients with spontaneous panic attacks. Sleep. 1989;12: 323–337.
93. Gardner WN, Meah MS, Bass C. Controlled study of respiratory responses during prolonged measurement in patients with chronic hyperventilation. Lancet. 1986;2: 826–830.
94. Ley R. Panic attacks during sleep: the hyperventilation-probability model. J Behav Ther Exp Psychiatry. 1988;19: 181–192.
95. Griez E, Zandbergen J, Lousberg H, van den Hout M. Effects of low pulmonary CO2 on panic anxiety. Compr Psychiatry. 1988;29: 490–497.
96. Zandbergen J, Lousberg HA, Pols H, de Loof C, Griez EJL. Hypercarbia vs. hypocarbia in panic disorder. J Affect Disord. 1990;18: 75–81.
97. Gorman JM, Askenazi J, Liebowitz MR, Fyer AJ, Stein J, Kinney J, Klein DF. Response to hyperventilation in a group of patients with panic disorder. Am J Psychiatry. 1984;41: 857–861.
98. Breier A, Charney DS, Henninger GR. Agoraphobia with panic attacks: development, diagnostic stability and course of illness. Arch Gen Psychiatry. 1986;43: 1029–1036.
99. Stein MB, Schmidt PJ, Rubinow DR, Uhde TW. Panic disorder and the menstrual cycle: panic disorder patients, healthy control subjects, and patients with premenstrual syndrome. Am J Psychiatry. 1989;146: 1299–1303.
100. Cameron OG, Kuttesch D, McPhee K, Curtis GC. Menstrual fluctuation in the symptoms of panic anxiety. J Affect Disord. 1988;15: 169–174.
101. Damas-Mora J, Davies L, Taylor W, Jenner FA. Menstrual respiratory changes and symptoms. Br J Psychiatry. 1980;136: 492–497.
102. England SJ, Farhi LE. Fluctuations in alveolar CO2 and in base excess during the menstrual cycle. Respir Physiol. 1976;26: 157–161.
103. Halbreich U, Endicott J, Goldstein S, Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand. 1986;74: 576–586.
104. Backstrom T. Gonadal hormones, ovulation and symptom formation. Clinical Neuropharmacology. 1990;13(suppl 2): 520–521.
105. Hammarback S, Damber J, Backstrom T. Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J Clin Endocrinol Metab. 1989;68: 125–130.
106. Backstrom T, Hammarback S. Johansson U, Bixo M. The pathogenesis of premenstrual postpartum and menopausal mood disorders. In: Demers LM, McGuire JL, Philips A, Rubinow DR, eds. Premenstrual, Postpartum, and Menopausal Mood Disorders. Baltimore, Md: Urban & Schwarzenberg; 1989.
107. Casper RF, Hearn MT. The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome. Am J Obstet and Gynecol. 1990;162: 105–109.
108. Hammarback S, Backstom T. Induced anovulation as treatment of premenstrual tension syndrome. Acta Obstet Gynecol Scand. 1988;67: 159–166.
109. Harrison WM, Sandberg D, Gorman JM, Fyer M, Nee J, Uy J, Endicott J. Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Res. 1989;27: 183–192.
110. Sandberg D, Endicott J, Harrison W, Nee J, Gorman J. Sodium lactate infusion in late luteal phase dysphoric disorder. Psych Res. In press.
111. Gorman JM, Liebowitz MR, Fyer AJ, Dillon D, Davies SO, Stein J, Klein DF. Lactate infusions in obsessive compulsive disorder. Am J Psychiatry. 1985;142: 864–866.
112. Liebowitz MR, Fyer AJ, Gorman JM, Dillon D, Davies S, Stein JM, Cohen BS, Klein DF. Specificity of lactate infusions in social phobia versus panic disorders. Am J Psychiatry. 1985;142: 947–950.
113. McGrath PJ, Stewart JW, Markowitz J, Liebowitz MR, Gorman JM, Quitkin FM, Klein DF. Lactate provocation of panic attacks in depressed outpatients. Psychiatry Res. 1988;25: 41–47.
114. Klein DF, Mannuzza S, Chapman T, Fyer AJ. Child panic revisited. J Am Acad Child Adolesc Psychiaty. 1992;31: 112–116.
115. White DP, Douglas NJ, Pickett CK, Weil JV, Zwillich CW. Sexual influence on the control of breathing. J Appl Physiol Respir Environ Exerc Physiol. 1983;54: 874–879.
116. Dennerstein L, Spencer-Gardner C, Gotts G, Brown JB, Smith MA, Burrows GD. Progesterone and the premenstrual syndrome; a double-blind crossover trial. Br Med J Clin Res. 1985;290: 1617–1621.
117. Osofsky HJ. Efficacious treatments of PMS: a need for further research. JAMA. 1990;264:387.
118. Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry. 1991;52: 290–293.
119. Backstrom, T, Baird, DT, Bancroft, J, Bixo, M, Hammarback, S, Sanders, D, Smith, S, Zetterlund, B. Endocrinological aspects of cyclical mood changes during the menstrual cycle or the premenstrual syndrome. J Psychosomatic Obstet Gynaecol. 1983;2: 8–20.
120. Reid RL. Endogenous opioid activity in premenstrual syndrome. Lancet. 1983;2:786.
121. Clapp JF, Seaward BL, Sleamaker RH, Hiser J. Maternal physiologic adaptations to early human pregnancy. Am J Obstet Gynecol. 1988;159: 1456–1460.
122. Fadel HE, Northrop G, Misenhimer HR, Harp RJ. Normal pregnancy: a model of sustained respiratory alkalosis. J Perinat Med. 1979;7: 195–201.
123. Liberatore SM, Pistelli R, Patalano F, Moneta E, Incalzi RA, Ciappi G. Respiratory function during pregnancy. Respiration. 1984;46: 145–150.
124. Lopatin VA. Some mechanisms of changes in external respiration during the menstrual cycle and pregnancy. Hum Physiol. 1979;5: 134–143.
125. Lucius H, Gahlenbeck H, Kleine H-O, Fabel H, Bartels H. Respiratory functions, buffer system, and electrolyte concentrations of blood during human pregnancy. Respir Physiol. 1970;9: 311–317.
126. Bing E. Six Lessons for an Easier Childbirth. New York, NY: Bantam Books; 1982.
127. Metz A, Sichel DA, Goff DC. Postpartum panic disorder. J Clin Psychiatry. 1988;49: 278–279.
128. Kraus RP. Postpartum anxiety disorder. J Clin Psychiatry. 1989;50:268.
129. Bybee P. Postpartum anxiety disorder. J Clin Psychiatry. 1989;50:268.
130. Fisch RZ. Postpartum anxiety disorder. J Clin Psychiatry. 1989;50: 268–269.
131. Metz A, Goff DC, Sichel DA. Reply: postpartum anxiety disorder. J Clin Psychiatry. 1989;50:269.
132. Panksepp J. Posterior pituitary hormones and separation distress in chicks. Neurosci Abstracts. 1988;14:287.
133. Insel TR. Oxytocin: a neuropeptide for affiliation: evidence from behavioral, receptor autoradiographic, and comparative studies. Psychoneuroendocrinology. 1992;17: 3–35.
134. Boulougouris JC, Rabavilas AD, Stefanis CN, Vaidakis N, Tabouratzis DG. Epidemic faintness: a psychophysiological investigation. Psychiatr Clin. 1981;14: 215–225.
135. Sparks PJ, Simon GE, Katon WJ, Altman LC, Ayars GH, Johnson RL. An outbreak of illness among aerospace workers. West J Med. 1990;153: 28–33.
136. Boxer PA, Singal M, Hartle RW. An epidemic of psychogenic illness in an electronics plant. J Occup Medicine. 1984;26: 381–385.
137. Struewing JP, Gray GC. An epidemic of respiratory complaints exacerbated by mass psychogenic illness in a military recruit population. Am J Epidemiol. 1990;132: 1120–1129.
138. Gittelman-Klein R, Klein DF. The relationship between separation anxiety and panic and agoraphobic disorders. Psychopathology. 1984;17: 56–65.
139. Ayuso JL, Alfonso S, Rivera A. Childhood separation anxiety and panic disorder: a comparative study. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13: 665–671.
140. Small GW, Nicholi AM. Mass hysteria among schoolchildren. Arch Gen Psychiatry. 1982;39: 721–724.
141. Small GW, Propper MW, Randolph ET, Eth S. Mass hysteria among student performers: social relationship as a symptom predictor. Am J Psychiatry. 1991;9: 1200–1205.
142. Jacobs S, Hansen F, Kasl S, Ostfeld A, Berkman L, Kim K. Anxiety disorders during acute bereavement: risk and risk factors. J Clin Psychiatry. 1990;51: 269–274.
143. Tweed JL, Schoenbach VJ, George LK, Blazer DG. The effects of childhood parental death and divorce on 6-month history of anxiety disorders. Br J Psychiatry. 1989;154: 823–828.
144. Van der Molen GM, van den Hout MA, van Dieren AC, Griez E. Childhood separation anxiety and adult onset panic disorders. J Anxiety Disord. 1989;3: 97–106.
145. Eldridge FL, Millhorn DE. Central regulation of respiration by endogenous neurotransmitters and neuromodulators. Ann Rev Physiol. 1981;43: 121–135.
146. Klein DF. Panic, separation anxiety, and endorphines. Behav Brain Sci. 1982;3: 436–437.
147. Panksepp J, Siviy SM, Normansell LA. Brain opioids and social emotions. In: Reite M, Fields T, eds. The Psychobiology of Attachment and Separation. Orlando, Fla; Academic Press Inc; 1985: 3–50.
148. Panksepp J, Bean NJ, Bishop P, Vilberg T, Sahley TL. Opioid blockade and social comfort in chicks. Pharmacol Biochem Behav. 1980;13: 673–683.
149. Akiyama Y, Nishimura M, Suzuki A, Yamamoto M, Kishi F, Kawakami Y. Naloxone increases ventilatory response to hypercapnic hypoxia in healthy adult humans. Am Rev Respir Dis. 1990;142: 301–305.
150. Stark RD, Sharman MP, Percival PG, Lewis JA. Effects of codeine on the respiratory responses to exercise in healthy subjects. Br J Clin Pharmacol. 1983;15: 355–359.
151. Ericksson E, Westberg P, Thuresson K, Modigh K, Ekman R, Widerlov E. Increased cerebrospinal fluid levels of endorphin immunoreactivity in panic disorder. Neuropsychopharmacology. 1989;12: 225–228.
152. Post RM, Pickar D, Ballenger JC, Naber D, Rubinow DR. Endogenous opiates in cerebrospinal fluid: relationship to mood and anxiety. In: Post RM, Ballenger JC, eds. Neurobiology of Mood Disorders. Baltimore, Md: Williams & Wilkins; 1984: 356–368.
153. George DT, Adinoff B, Ravitz B, Nutt DJ, DeJone J, Berrettini W, Mefford, Costa E, Linnoila M. A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism. Acta Psychiatr Scand. 1990;82: 1–7.
154. Eriksson E, Westberg P, Alling C, Thuresson K, Modigh K. Cerebrospinal fluid levels of monoamine metabolites in panic disorder. Psychiatry Res. 1991;36: 243–251.
155. Lepola U, Jolkkonen J, Pitkanen A, Riekkinen P, Rimon R. Cerebrospinal fluid monoamine metabolites and neuropeptides in patients with panic disorder. Ann Med. 1990;22: 237–239.
156. Matthews AW. The relationship between central carbon dioxide sensitivity and clinical features in patients with chronic airways obstruction. QJ Med. 1977;182: 179–195.
157. Yellowlees PM, Haynes S, Potts N, Ruffin RE. Psychiatric morbidity in patients with life-threatening asthma: initial report of a controlled study. Med J Aust. 1988;149: 246–249.
158. Yellowlees PM, Alpers JH, Bowden JJ, Bryant GD, Ruffin RE. Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust. 1987;146: 305–307.
159. Yellowlees PM, Kalucy RS. Psychobiological aspects of asthma and the consequent research implications. Chest. 1990;97: 628–634.
160. Yellowlees PM, Ruffin RE. Psychological defenses and coping styles in patients following a life threatening attack of asthma. Chest. 1989;95: 1298–1303.
161. Karajgi B, Rifkin A, Doddi S, Kolli R. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry. 1990;147: 200–201.
162. Baron C, Lamarre A, Veilleux P, Ducharme G, Spier S, Lapierre JG. Psychomaintenance of childhood asthma: a study of 34 children. J Asthma. 1986;23: 69–79.
163. Brooks CM, Richards JM, Bailey WC, Martin B, Windsor RA, Soong SJ. Subjective symptomatology of asthma in an outpatient population. Psychosom Medicine. 1989;51: 102–108.
164. Jurenic GC. Identification of subgroups of childhood asthmatics: a review. J Asthma. 1988;925: 15–25.
165. Burns BH, Howell JBL. Disproportionately severe breathlessness in chronic bronchitis. QJ Med. 1969;38: 277–294.
166. Edlund MJ, McNamara ME, Millman RP. Sleep apnea and panic attacks. Compr Psychiatry. 1991;32: 130–132.
167. Patterson JL Jr. Carotid bodies, breath-holding and dyspnea. N Engl J Med. 1974;290: 853–854.
168. Stulbarg MS, Winn WR. Bilateral carotid body resection for the relief of dyspnea in severe chronic obstructive pulmonary disease. Chest. 1989; 95: 1123–1128.
169. Van Doorn P, Folgering H, Colla P. Control of the end-tidal PCO2 in the hyperventilation syndrome: effects of biofeedback and breathing instructions compared. Bull Eur Physiopathol Respir. 1982;18: 829–836.
170. Clark DM, Salkovskis PM. Respiratory control as a treatment for panic attacks. J Behav Ther Exp Psychiatry. 1985;16: 23–32.
171. Franklin JA. A 6-year followup of the effectiveness of respiratory retraining, in-situ isometric relaxation, and cognitive modification in the treatment of agoraphobia. Behav Modif. 1989;13: 139–167.
172. Van den Hout MA, van der Molen GM, Griez E, Lousberg H, Nansen A. Reduction of CO2-induced anxiety in patients with panic attacks after repeated CO2 exposure. Am J Psychiatry. 1987;144: 788–791.
173. Haslam MT. The relationship between the effect of lactate infusion on anxiety states, and their emelioration by carbon dioxide inhalation. Br J Psychiatry. 1974;125: 88–90.
174. Hoes MJ, Colla P, Folgering H. Clomipramine treatment of hyperventilation syndrome. Pharmakopsychiatrie Neuro-Psychopharmakologie. 1980;13: 25–28.
175. Eriksson E, Humble M. Serotonin in psychiatric pathophysiology: a review of data from experimental and clinical research. In: Pohl R, Gershon S, eds. The Biological Basis of Psychiatric Treatment: Progress in Basic and Clinical Pharmacology. Basel, Switzerland: Karger; 1990;3: 66–119.
176. Norton GR, Harrison B, Hauch J, Rhodes L. Characteristics of people with infrequent panic attacks. J Abnorm Psychol. 1985;94: 216–221.
177. Keyl PM, Eaton WW. Risk factors for the onset of panic disorder and other panic attacks in a prospective, population-based study. Am J Epidemiol. 1990;131: 301–311.
178. Buller R, Maier W, Benkert O. Clinical subtypes of panic disorder: their descriptive and prospective validity. J Affect Disord. 1986;11: 105–114.
179. Noyes R, Reich J, Christiansen J, Suelzer M, Pfohl B, Coryell WA. Outcome of panic disorder. Arch Gen Psychiatry. 1990;47: 809–818.
180. Turner SM, Williams SL, Beidel DC, Mezzich JE. Panic disorder and agoraphobia with panic attacks: covariation along the dimensions of panic and agoraphobic fear. J Abnorm Psychol. 1986;95: 384–388.
181. Maier W, Buller R. One-year follow-up of panic disorder. Eur Arch Psychiatry Neurol Sci. 1988;238: 105–109.
182. Gross PR. Generalized anxiety symptoms in phobic disorders and anxiety states: a test of the worry hypothesis. J Anxiety Disord. 1989;3: 159–169.
183. Katerndahl DA. The sequence of panic symptoms. J Fam Pract. 1988;26: 49–52.
184. Katerndahl DA. Factors in the panic-agoraphobia transition. J Am Board Fam Pract. 1989;2: 10–16.
185. Katerndahl DA, Gabel LL, Monk JS. Comparative symptomatology of phobic and nonphobic panic attacks. Fam Pract Res J. 1986;6: 106–113.
186. Gold PW, Pigott TA, Kling MA, Brandt HA, Kalogeras K, Demitrack MA, Geracioti TD. Hypothalamic-pituitary-adrenal axis in panic disorder. In: Ballenger JC, ed. Neurobiology of Panic Disorder. New York, NY: Alan R Liss Inc; 1990: 313–320.
187. Weissman MM. Panic and generalized anxiety: are they separate disorders? J Psychiatr Res. 1990;24(suppl2): 157–162.
188. Klein DF. The prospective study of bereavement. Arch Found Thanatol. 1969;1:13.